From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane.
💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr.
🔬 Their Truenat platform, is a battery-power
See More
Anonymous 5
Hey I am on Medial • 2m
I would prefer life sciences, hardware or deep tech startups over gig and saas
SAAS is crowded now. It's time to focus on hardware startups
6 replies3 likes
Omkar Rao Budi
Portfolio Management... • 3m
Looking for a Tech Co Founder for my B2B Saas Startup .
1. Should know how to build a saas platform completely, deep understanding of tecg
2. 100% all in, full time
3. Should ideally have worked in corporates or startups for 1-2 years
4. Preferabl
🚨 INDIA VS CHINA IN DEEP TECH: WHY ARE WE LAGGING? 🤔
China’s startups are CRUSHING IT in AI, semiconductors, EVs, and battery tech. Meanwhile, India’s focus? Food delivery & fantasy sports. 😑 In 2024, China’s AI/semiconductor VC funding hit $12.3